Work

Supplementary Data from Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Data from Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer

DOI: 10.1158/1078-0432.22470513

Authors: Susan Slovin, Syed Hussain, Fred Saad, Jorge Garcia, Joel Picus, Roberta Ferraldeschi, Mateus Crespo, Penelope Flohr, Ruth Riisnaes, Chihche Lin, Harold Keer, Aram Oganesian, Paul Workman, Johann de Bono

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362405835

Cites:

Cited by:

Related to: 10